OM-8980
- 1 July 1994
- journal article
- drug evaluation
- Published by Springer Nature in Clinical Immunotherapeutics
- Vol. 2 (1) , 65-77
- https://doi.org/10.1007/bf03258523
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- New focus on treatment for rheumatoid arthritisCurrent Opinion in Rheumatology, 1993
- Intervention with immunomodulatory agents: new pharmacological developmentsBailliere's Clinical Rheumatology, 1992
- Inhibition of antibody-dependent allergic autocytotoxicity in rheumatoid arthritis by OM-89International Journal of Immunopharmacology, 1991
- Effects of a Hydrosoluble Bacterial Extract from Escherichia Coli (OM-89) on Cytokine Production by Peripheral Blood Mononuclear Cells from Healthy Subjects and Patients with Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1991
- Action of A Mycotoxin (Diacetoxyscirpenol) on the Immune Response of the Mouse-Interaction with An Immunomodulator (Om-89)Immunopharmacology and Immunotoxicology, 1990
- Effect in vitro of a bacterial extract (OM-89) on interleukin 1 and interleukin 2 production by peripheral blood mononuclear cells from healthy subjects and rheumatoid arthritis patientsInternational Journal of Immunopharmacology, 1990
- Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritisRheumatology International, 1989
- Enhancement of Cytokine Production and Natural Killer Activity By an Escherichia Coli ExtractOncology Research and Treatment, 1989
- Enhancement of the Humoral Immune Response and Resistance to Bacterial Infection in Mice by the Oral Administration of a Bacterial Immunomodulator (OM-89)Immunopharmacology and Immunotoxicology, 1988
- Effect of a Bacterial Extract on Cellular and Humoral Immiine Responses in HumansImmunopharmacology and Immunotoxicology, 1986